This hypothesis is supported by the study of Chan et al. [44] that the levels of COX-2 mRNA quantified by reverse transcription-PCR were increased 150-fold in the head and neck squamous cell carcinoma compared with normal oral mucosa. The gene discussed is PTGS2; the disease is head and neck squamous cell carcinoma.